An inhalable nanoparticulate STING agonist synergizes with radiotherapy to confer long-term control of lung metastases
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
An inhalable nanoparticulate STING agonist synergizes with radiotherapy to confer long-term control of lung metastases
Authors
Keywords
-
Journal
Nature Communications
Volume 10, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-11-08
DOI
10.1038/s41467-019-13094-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Endosomolytic polymersomes increase the activity of cyclic dinucleotide STING agonists to enhance cancer immunotherapy
- (2019) Daniel Shae et al. Nature Nanotechnology
- Extended release of perioperative immunotherapy prevents tumor recurrence and eliminates metastases
- (2018) Chun Gwon Park et al. Science Translational Medicine
- Risk factors and survival outcomes in patients with breast cancer and lung metastasis: a population-based study
- (2018) Weikai Xiao et al. Cancer Medicine
- TLR7/8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enhance cancer immunotherapy
- (2018) Christopher B. Rodell et al. Nature Biomedical Engineering
- Combined local immunostimulatory radioisotope therapy and systemic immune checkpoint blockade imparts potent antitumour responses
- (2018) Yu Chao et al. Nature Biomedical Engineering
- Tumor-derived IFN triggers chronic pathway agonism and sensitivity to ADAR loss
- (2018) Huayang Liu et al. NATURE MEDICINE
- Antigen-capturing nanoparticles improve the abscopal effect and cancer immunotherapy
- (2017) Yuanzeng Min et al. Nature Nanotechnology
- Convection-enhanced Delivery of Therapeutics for Malignant Gliomas
- (2017) Ryuta SAITO et al. NEUROLOGIA MEDICO-CHIRURGICA
- DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity
- (2017) Claire Vanpouille-Box et al. Nature Communications
- Modulating Both Tumor Cell Death and Innate Immunity Is Essential for Improving Radiation Therapy Effectiveness
- (2017) Qiuji Wu et al. Frontiers in Immunology
- Folate-targeted pH-responsive calcium zoledronate nanoscale metal-organic frameworks: Turning a bone antiresorptive agent into an anticancer therapeutic
- (2016) Kin Man Au et al. BIOMATERIALS
- Tumor Interferon Signaling Regulates a Multigenic Resistance Program to Immune Checkpoint Blockade
- (2016) Joseph L. Benci et al. CELL
- The tumour microenvironment harbours ontogenically distinct dendritic cell populations with opposing effects on tumour immunity
- (2016) Damya Laoui et al. Nature Communications
- Antitumor Efficacy of Radiation plus Immunotherapy Depends upon Dendritic Cell Activation of Effector CD8+ T Cells
- (2016) S. J. Dovedi et al. Cancer Immunology Research
- Regulating the surface poly(ethylene glycol) density of polymeric nanoparticles and evaluating its role in drug delivery in vivo
- (2015) Xiao-Jiao Du et al. BIOMATERIALS
- Radiotherapy Combined with Novel STING-Targeting Oligonucleotides Results in Regression of Established Tumors
- (2015) J. R. Baird et al. CANCER RESEARCH
- Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer
- (2015) Christina Twyman-Saint Victor et al. NATURE
- Convertible MRI contrast: Sensing the delivery and release of anti-glioma nano-drugs
- (2015) Liang Zhang et al. Scientific Reports
- In-situ tumor vaccination: Bringing the fight to the tumor
- (2015) Robert H Pierce et al. Human Vaccines & Immunotherapeutics
- TIMgenes: a family of cell surface phosphatidylserine receptors that regulate innate and adaptive immunity
- (2015) Gordon J. Freeman et al. IMMUNOLOGICAL REVIEWS
- Dissecting the Tumor Myeloid Compartment Reveals Rare Activating Antigen-Presenting Cells Critical for T Cell Immunity
- (2014) Miranda L. Broz et al. CANCER CELL
- Intratumoral Immunization: A New Paradigm for Cancer Therapy
- (2014) A. Marabelle et al. CLINICAL CANCER RESEARCH
- STING-Dependent Cytosolic DNA Sensing Mediates Innate Immune Recognition of Immunogenic Tumors
- (2014) Seng-Ryong Woo et al. IMMUNITY
- STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors
- (2014) Liufu Deng et al. IMMUNITY
- Phosphatidylserine-targeted bimodal liposomal nanoparticles for in vivo imaging of breast cancer in mice
- (2014) Liang Zhang et al. JOURNAL OF CONTROLLED RELEASE
- Type I interferons directly inhibit regulatory T cells to allow optimal antiviral T cell responses during acute LCMV infection
- (2014) Shivani Srivastava et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Image-guided radiotherapy platform using single nodule conditional lung cancer mouse models
- (2014) Grit S. Herter-Sprie et al. Nature Communications
- Stereotactic Radiation Therapy Augments Antigen-Specific PD-1-Mediated Antitumor Immune Responses via Cross-Presentation of Tumor Antigen
- (2014) A. B. Sharabi et al. Cancer Immunology Research
- Adjuvants That Improve the Ratio of Antigen-Specific Effector to Regulatory T Cells Enhance Tumor Immunity
- (2013) R. Perret et al. CANCER RESEARCH
- Tumor-infiltrating DCs suppress nucleic acid–mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1
- (2012) Shigeki Chiba et al. NATURE IMMUNOLOGY
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- (2012) Julie R. Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cyclic GMP-AMP Is an Endogenous Second Messenger in Innate Immune Signaling by Cytosolic DNA
- (2012) J. Wu et al. SCIENCE
- Cyclic GMP-AMP Synthase Is a Cytosolic DNA Sensor That Activates the Type I Interferon Pathway
- (2012) L. Sun et al. SCIENCE
- Metastatic Behavior in Melanoma: Timing, Pattern, Survival, and Influencing Factors
- (2012) Faruk Tas Journal of Oncology
- Calcium phosphate nanoparticles with an asymmetric lipid bilayer coating for siRNA delivery to the tumor
- (2011) Jun Li et al. JOURNAL OF CONTROLLED RELEASE
- Host type I IFN signals are required for antitumor CD8+T cell responses through CD8α+dendritic cells
- (2011) Mercedes B. Fuertes et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Type I interferon is selectively required by dendritic cells for immune rejection of tumors
- (2011) Mark S. Diamond et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Radiation Enhances Regulatory T Cell Representation
- (2010) Evelyn L. Kachikwu et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- In Situ Vaccination With a TLR9 Agonist Induces Systemic Lymphoma Regression: A Phase I/II Study
- (2010) Joshua D. Brody et al. JOURNAL OF CLINICAL ONCOLOGY
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Fractionated but Not Single-Dose Radiotherapy Induces an Immune-Mediated Abscopal Effect when Combined with Anti-CTLA-4 Antibody
- (2009) M. Z. Dewan et al. CLINICAL CANCER RESEARCH
- Multi-Institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Liver Metastases
- (2009) Kyle E. Rusthoven et al. JOURNAL OF CLINICAL ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started